PERSONNEL
Frank E. O'Donnell, Jr. MD
Chairman and CEO
Dr. O’Donnell has served as Manager of Hopkins Capital Group since its founding in 1999. Dr. O’Donnell has been Chairman of the Board of Accentia Biopharmaceuticals, Inc. (“ABPI”), a holding company with commercialization assets in specialty pharmaceuticals and biologics, since the company’s founding in March 2002, and has served CEO since September 2003. Dr. O’Donnell also served as President of ABPI from September 2003 through November 2004. Since February 2009, Dr. O’Donnell has been Chief Executive Officer and Chairman of Biovest International, Inc. (“BVTI”), a majority-owned subsidiary of ABPI. Since 2003, Dr. O’Donnell had been a Director and Vice-Chairman (non-executive) of BVTI. Since May 2002, Dr. O’Donnell has been Chairman and a Director of BioDelivery Sciences International, Inc. (“BDSI”), a publicly traded drug delivery technology company. Dr. O’Donnell is a 1975 summa cum laude graduate of the Johns Hopkins School of Medicine. He received specialty training at the Wilmer Ophthalmological Institute, Johns Hopkins Hospital. He is the former Professor and Chairman, Department of Ophthalmology, St. Louis University School of Medicine. Dr. O’Donnell has published over 30 peer-reviewed scientific articles and has been awarded over 34 U.S. patents. He is the recipient of the 2000 Jules Stein Award from Retinitis Pigmentosa International. He is a Trustee for St. Louis University.
James A. McNulty, CPA
Chief Financial Officer
Mr. McNulty has served, since May 2000, as our Chief Financial Officer. Mr. McNulty also serves as Secretary, Treasurer and Chief Financial Officer of BioDelivery Sciences, Inc. Mr. McNulty also serves as Treasurer and Corporate Secretary of Accentia Biopharmaceuticals, Inc., and through December 31, 2007 served as Chief Financial Officer for Biovest International, Inc., a majority-owned subsidiary of ABPI. Mr. McNulty has performed accounting and consulting services as a Certified Public Accountant since 1975. He co-founded Pender McNulty & Newkirk, which became one of Florida’s largest regional CPA firms, and was a founder/principal of the CPA firms McNulty & Company, and McNulty Garcia & Ortiz. He served as CFO of Star Scientific, Inc. from October 1998 to May 2000. From June 2000 through January 2002 he served as CFO/COO of American Prescription Providers, Inc. He is a published co-author, with Pat Summerall, of Business Golf, the Art of Building Relationships on the Links. Mr. McNulty is a graduate of University of South Florida, a licensed Certified Public Accountant, a member of the American and Florida Institutes of CPA’s and is a board member of the Central Florida chapter of Financial Executives International.
Samuel S. Duffey
General Legal Counsel
Mr. Duffey is our General Counsel. Also serving as General Counsel to Accentia Biopharmaceuticals, Inc. since 2003, he was named as their President in 2008. Prior to that, Mr. Duffey practiced business law with Duffey and Dolan P.A., beginning in 1992. He is also a consultant, providing business and marketing advice to various client companies regarding domestic and international marketing and finance. Mr. Duffey was employed as a staff trial attorney with the United States Securities and Exchange Commission, and has practiced business law for more than 20 years, assisting businesses in all aspects of growth. He has assisted numerous companies in conducting initial public offerings. From February 2000 to September 2003, Mr. Duffey served as the non-executive chairman and as a member of the board of directors of Invisa, Inc., a small publicly held safety company, and from October 2001 to May 2004, Mr. Duffey also served as the non-executive chairman and as a member of the board of directors of FlashPoint International, Inc., a publicly held automotive parts company, which is currently named Navitrak International Corporation. Mr. Duffey received his B.A. and J.D. degrees with honors from Drake University.
Carlos F. Santos, Ph.D.
Pharmaceutical Product Development
Dr. Santos is our Chief Science Officer, contributing to the HCG portfolio of companies since 1998. He is currently the Senior Vice President of Product Development and Regulatory Affairs for Biovest International, Inc., managing responsibilities related to pharmaceutical product development, intellectual property design, regulatory strategy and corporate development planning activities. Dr. Santos also serves as Chief Science Officer for Accentia Biopharmaceuticals, Inc. He is a graduate of the University of Michigan, where he earned a PhD in Bioinformatics, and Washington University, St. Louis, where he earned a B.S. in Computer Science. At the University of Michigan, he developed automated natural language processing systems to integrate high-throughout genomic experimental data with known protein interaction pathways in metastatic prostate cancer progression. He also led the development of large-scale automated search and summarization engines for biomedical documents at the University of Michigan’s National Center for Integrative Biomedical Informatics (NCIB). From 1998 – 2001, he was a researcher at Washington University’s Institute for Biomedical Computing, now known as the Center for Computational Biology.
Michelle L. Brown
Controller
Michelle L. Brown serves as our Controller and has been with the Hopkins portfolio companies since 2002. She also serves as Financial Reporting Manager of BioDelivery Sciences International, Inc. (NASDAQ: BDSI). Ms. Brown holds an Associates’ degree in Business Administration and currently attends the University of South Florida. Ms. Brown is a member of The Association for Accountants and Financial Professionals in Business.
Josue D. Moran
Director of Technology Assessment
Josue D. Moran, M.s.B. serves as our Business Development Associate. He received his B.S. in Biomedical Science with a minor in Biophysics and Public Health. He also holds a M.S. degree in Biotechnology from the University Of South Florida College Of Medicine.
Tammy L. Tolman
Paralegal
Tammy L. Tolman, B.A.S, joined the Hopkins team as Paralegal in 2010. She was awarded a Bachelor’s Degree in Paralegal Studies with cum laude honors from St. Petersburg College, the only American Bar Association accredited Paralegal program in Florida. Her experience in the legal field includes business law, civil defense and family law. She intends to pursue her MBA beginning in the summer of 2012 with Florida State University.